{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:26:28Z","timestamp":1780921588637,"version":"3.54.1"},"reference-count":49,"publisher":"The Pediatric Pharmacy Association","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:p>Postural orthostatic tachycardia syndrome (POTS) is a chronic illness with unknown mortality and high morbidity, often diagnosed in the adolescent years. Published literature regarding POTS primarily focuses on the adult population, and guidance on treatment in pediatrics is sparse. The purpose of this clinical review is to evaluate the current literature on the management of POTS in pediatric patients. A search was conducted using the Cochrane database, Google Scholar, and PubMed. Studies were included if they evaluated the management of POTS, primarily in pediatric patients. Case reports and series were excluded. Eight published studies met the inclusion and exclusion criteria. To date, there are no US Food and Drug Administration-approved agents for the treatment of POTS. However, select pharmacological therapies have shown positive outcomes by addressing symptom origins, such as providing heart rate control, peripheral autonomic modulation, and targeting hypovolemia. Targeted pharmacological therapies studied in children and young adults include ivabradine, metoprolol, midodrine, pyridostigmine, intravenous crystalloid fluids, and fludrocortisone. Before adding pharmacotherapeutic interventions, non-pharmacologic interventions such as patient education, avoidance of symptom-triggering environments and medications, dietary fluid and sodium supplementation, exercise, and use of compression garments should be first attempted. Although the body of evidence for the management of POTS is expanding, additional research is needed to determine safe and efficacious dosing and establish clear guidelines for POTS in the pediatric population.<\/jats:p>","DOI":"10.5863\/1551-6776-29.5.456","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T10:52:26Z","timestamp":1728903146000},"page":"456-467","source":"Crossref","is-referenced-by-count":5,"title":["Management of Postural Orthostatic Tachycardia Syndrome in Pediatric Patients: A Clinical Review"],"prefix":"10.5863","volume":"29","author":[{"given":"Peter","family":"Huynh","sequence":"first","affiliation":[{"name":"Department of Pharmacy (PH), Cedars Sinai Medical Center, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (AB), Phoenix VA Health Care System, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Campisi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (LC), Children\u2019s Health, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Mruk","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (ALM), Banner University Medical Center-Phoenix, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (TN), Phoenix Children\u2019s, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Raschka","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (MR), Children\u2019s Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titilola","family":"Afolabi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (TMA), Le Bonheur Children\u2019s Hospital, Memphis TN"},{"name":"Department of Clinical Pharmacy and Translational Sciences (TMA), University of Tennessee, College of Pharmacy, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3883","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"issue":"5","key":"2024101410522347600_i2331-348X-29-5-456-b01","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0002-9343(82)90559-9","article-title":"Postural tachycardia syndrome. Reversal of sympathetic hyperresponsiveness and clinical improvement during sodium loading","volume":"72","author":"Rosen","year":"1982","journal-title":"Am J Med"},{"issue":"6","key":"2024101410522347600_i2331-348X-29-5-456-b02","doi-asserted-by":"crossref","first-page":"e2021054945","DOI":"10.1542\/peds.2021-054945","article-title":"Pediatric postural orthostatic tachycardia syndrome: where we stand","volume":"149","author":"Boris","year":"2022","journal-title":"Pediatrics"},{"key":"2024101410522347600_i2331-348X-29-5-456-b03","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.hrthm.2015.03.029","article-title":"2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope","volume":"12","author":"Sheldon","year":"2015","journal-title":"Heart Rhythm"},{"issue":"5","key":"2024101410522347600_i2331-348X-29-5-456-b04","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1017\/S1047951117002888","article-title":"Demographics of a large pediatric postural orthostatic tachycardia syndrome program","volume":"28","author":"Boris","year":"2018","journal-title":"Cardiol Young"},{"issue":"8","key":"2024101410522347600_i2331-348X-29-5-456-b05","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1177\/0883073820916260","article-title":"Pediatric-onset postural orthostatic tachycardia syndrome in a single tertiary care center","volume":"35","author":"Staples","year":"2020","journal-title":"J Child Neurol"},{"key":"2024101410522347600_i2331-348X-29-5-456-b06","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.autneu.2018.05.004","article-title":"Postural orthostatic tachycardia syndrome in children and adolescents","volume":"215","author":"Boris","year":"2018","journal-title":"Auton Neurosci"},{"key":"2024101410522347600_i2331-348X-29-5-456-b07","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"21","author":"Freeman","year":"2011","journal-title":"Clin Auton Res"},{"key":"2024101410522347600_i2331-348X-29-5-456-b08","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3389\/fped.2020.00474","article-title":"Postural tachycardia syndrome in children and adolescents: pathophysiology and clinical management","volume":"8","author":"Chen","year":"2020","journal-title":"Front Pediatr"},{"issue":"7","key":"2024101410522347600_i2331-348X-29-5-456-b09","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1017\/S1047951120001341","article-title":"Ivabradine in children with postural orthostatic tachycardia syndrome: a retrospective study","volume":"30","author":"Towheed","year":"2020","journal-title":"Cardiol Young"},{"issue":"2","key":"2024101410522347600_i2331-348X-29-5-456-b10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1017\/S1047951122000580","article-title":"Cardiac arrhythmias in postural tachycardia syndrome and orthostatic intolerance","volume":"33","author":"Hong","year":"2023","journal-title":"Cardiol Young"},{"key":"2024101410522347600_i2331-348X-29-5-456-b11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3389\/fneur.2020.00525","article-title":"Update of individualized treatment strategies for postural orthostatic tachycardia syndrome in children","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Neurol"},{"issue":"1","key":"2024101410522347600_i2331-348X-29-5-456-b12","first-page":"2395","article-title":"Non-pharmacological and pharmacological management of cardiac dysautonomia syndromes","volume":"13","author":"Lei","year":"2020","journal-title":"J Atr Fibrillation"},{"issue":"1","key":"2024101410522347600_i2331-348X-29-5-456-b13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40256-017-0248-x","article-title":"Ivabradine in postural orthostatic tachycardia syndrome: preliminary experience in children","volume":"18","author":"Delle Donne","year":"2018","journal-title":"Am J Cardiovasc Drugs"},{"issue":"2","key":"2024101410522347600_i2331-348X-29-5-456-b14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1540-8159.2008.02207.x","article-title":"Outcomes in adolescents with postural orthostatic tachycardia syndrome treated with midodrine and beta-blockers","volume":"32","author":"Lai","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"2024101410522347600_i2331-348X-29-5-456-b15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1253\/circj.CJ-10-0514","article-title":"Midodrine hydrochloride is effective in the treatment of children with postural orthostasis tachycardia syndrome","volume":"75","author":"Chen","year":"2011","journal-title":"Circ J"},{"issue":"4","key":"2024101410522347600_i2331-348X-29-5-456-b16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.amjcard.2014.05.039","article-title":"Usefulness of plasma copeptin as a biomarker to predict the therapeutic effectiveness of metoprolol for postural tachycardia syndrome in children","volume":"114","author":"Zhao","year":"2014","journal-title":"Am J Cardiol"},{"key":"2024101410522347600_i2331-348X-29-5-456-b17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12967-014-0249-3","article-title":"Orthostatic plasma norepinephrine level as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome","volume":"12","author":"Zhang","year":"2014","journal-title":"J Transl Med"},{"issue":"3","key":"2024101410522347600_i2331-348X-29-5-456-b18","doi-asserted-by":"crossref","first-page":"e0121913","DOI":"10.1371\/journal.pone.0121913","article-title":"Plasma C-type natriuretic peptide as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome","volume":"10","author":"Lin","year":"2015","journal-title":"PloS ONE"},{"key":"2024101410522347600_i2331-348X-29-5-456-b19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jpeds.2020.05.017","article-title":"Heart rate and heart rate difference predicted the efficacy of metoprolol on postural tachycardia syndrome in children and adolescents","volume":"224","author":"Wang","year":"2020","journal-title":"J Pediatr"},{"issue":"16","key":"2024101410522347600_i2331-348X-29-5-456-b20","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1097\/CM9.0000000000001698","article-title":"Baseline left ventricular ejection fraction associated with symptom improvements in both children and adolescents with postural tachycardia syndrome under metoprolol therapy","volume":"124","author":"Wang","year":"2021","journal-title":"Chin Med J"},{"key":"2024101410522347600_i2331-348X-29-5-456-b21","doi-asserted-by":"crossref","first-page":"808512","DOI":"10.3389\/fcvm.2021.808512","article-title":"Baseline corrected QT interval dispersion is useful to predict effectiveness of metoprolol on pediatric postural tachycardia syndrome","volume":"8","author":"Wang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2024101410522347600_i2331-348X-29-5-456-b22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12519-022-00677-4","article-title":"A predictive model of response to metoprolol in children and adolescents with postural tachycardia syndrome","volume":"19","author":"Xu","year":"2023","journal-title":"World J Pediatr"},{"issue":"4","key":"2024101410522347600_i2331-348X-29-5-456-b23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/CS20130222","article-title":"A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome","volume":"126","author":"Ross","year":"2014","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"2024101410522347600_i2331-348X-29-5-456-b24","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00246-013-0843-9","article-title":"Difference between supine and upright blood pressure associates to the efficacy of midodrine on postural orthostatic tachycardia syndrome (POTS) in children","volume":"35","author":"Deng","year":"2014","journal-title":"Pediatr Cardiol"},{"key":"2024101410522347600_i2331-348X-29-5-456-b25","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jpeds.2013.04.039","article-title":"Postural orthostatic tachycardia syndrome with increased erythrocytic hydrogen sulfide and response to midodrine hydrochloride","volume":"163","author":"Yang","year":"2013","journal-title":"J Pediatr"},{"key":"2024101410522347600_i2331-348X-29-5-456-b26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jacc.2012.04.025","article-title":"Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome","volume":"60","author":"Zhang","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2024101410522347600_i2331-348X-29-5-456-b27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jpeds.2014.04.032","article-title":"Plasma copeptin and therapeutic effectiveness of midodrine on postural tachycardia syndrome in children","volume":"165","author":"Zhao","year":"2014","journal-title":"J Pediatr"},{"key":"2024101410522347600_i2331-348X-29-5-456-b28","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.amjcard.2013.05.008","article-title":"Flow-mediated vasodilation as a predictor of therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome","volume":"112","author":"Liao","year":"2013","journal-title":"Am J Cardiol"},{"issue":"2","key":"2024101410522347600_i2331-348X-29-5-456-b29","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1345\/aph.1H458","article-title":"Pyridostigmine in the treatment of orthostatic intolerance","volume":"41","author":"Gales","year":"2007","journal-title":"Ann Pharmacother"},{"key":"2024101410522347600_i2331-348X-29-5-456-b30","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1540-8159.2011.03047.x","article-title":"Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience","volume":"34","author":"Kanjwal","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"issue":"2","key":"2024101410522347600_i2331-348X-29-5-456-b31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00246-015-1274-6","article-title":"Intravenous hydration for management of medication-resistant orthostatic intolerance in the adolescent and young adult","volume":"37","author":"Moak","year":"2016","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"2024101410522347600_i2331-348X-29-5-456-b32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MPG.0000000000000305","article-title":"Effect of fludrocortisone acetate on chronic unexplained nausea and abdominal pain in children with orthostatic intolerance","volume":"59","author":"Fortunato","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2024101410522347600_i2331-348X-29-5-456-b33","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3390\/children10071093","article-title":"Predicting therapeutic efficacy of pharmacological treatments in children with postural orthostatic tachycardia syndrome: a mini-review","volume":"10","author":"Fan","year":"2023","journal-title":"Children"},{"key":"2024101410522347600_i2331-348X-29-5-456-b34","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/s41395-018-0215-4","article-title":"Postural tachycardia syndrome (POTS) and the GI tract: a primer for the gastroenterologist","volume":"113","author":"DiBaise","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"14","key":"2024101410522347600_i2331-348X-29-5-456-b35","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1177\/0883073820948679","article-title":"Treatment of postural orthostatic tachycardia syndrome with medication: a systematic review","volume":"35","author":"Hasan","year":"2020","journal-title":"J Child Neurol"},{"key":"2024101410522347600_i2331-348X-29-5-456-b36","unstructured":"Midodrine product information\n          . Shire, Inc, January2017. Accessed December 28, 2022. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/019815s010lbl.pdf"},{"issue":"21","key":"2024101410522347600_i2331-348X-29-5-456-b37","doi-asserted-by":"crossref","first-page":"36843689","DOI":"10.3760\/cma.j.issn.0366-6999.20140244","article-title":"Clinical features and management of postural tachycardia syndrome in children: a single-center experience","volume":"127","author":"Li","year":"2014","journal-title":"Chin Med J"},{"issue":"12","key":"2024101410522347600_i2331-348X-29-5-456-b38","doi-asserted-by":"crossref","first-page":"e113625","DOI":"10.1371\/journal.pone.0113625","article-title":"Risk factors for postural tachycardia syndrome in children and adolescents","volume":"9","author":"Lin","year":"2014","journal-title":"PloS One"},{"key":"2024101410522347600_i2331-348X-29-5-456-b39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ppedcard.2018.01.003","article-title":"Systematic literature review of pathophysiology of postural orthostatic tachycardia syndrome (angiotensin II receptor subtype imbalance theory)","volume":"50","author":"Nagiub","year":"2018","journal-title":"Prog Pediatr Cardiol"},{"key":"2024101410522347600_i2331-348X-29-5-456-b40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jpeds.2019.07.041","article-title":"The benefits of oral rehydration on orthostatic intolerance in children with postural tachycardia syndrome","volume":"214","author":"Medow","year":"2019","journal-title":"J Pediatr"},{"key":"2024101410522347600_i2331-348X-29-5-456-b41","doi-asserted-by":"crossref","first-page":"102828","DOI":"10.1016\/j.autneu.2021.102828","article-title":"Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting-Part 1","volume":"235","author":"Vernino","year":"2021","journal-title":"Auton Neurosci"},{"issue":"6","key":"2024101410522347600_i2331-348X-29-5-456-b42","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s12264-020-00497-4","article-title":"Pathophysiology and individualized management of vasovagal syncope and postural tachycardia syndrome in children and adolescents: an update","volume":"36","author":"Liao","year":"2020","journal-title":"Neurosci Bull"},{"issue":"21","key":"2024101410522347600_i2331-348X-29-5-456-b43","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1161\/CIRCULATIONAHA.104.497594","article-title":"Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome","volume":"111","author":"Raj","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"2024101410522347600_i2331-348X-29-5-456-b44","doi-asserted-by":"crossref","first-page":"e000395","DOI":"10.1161\/JAHA.113.000395","article-title":"Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome","volume":"2","author":"Green","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2024101410522347600_i2331-348X-29-5-456-b45","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/j.jacc.2010.02.043","article-title":"Cardiac origins of the postural orthostatic tachycardia syndrome","volume":"55","author":"Fu","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2024101410522347600_i2331-348X-29-5-456-b46","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.hrthm.2015.12.012","article-title":"The international POTS registry: evaluating the efficacy of an exercise training intervention in a community setting","volume":"13","author":"George","year":"2016","journal-title":"Heart Rhythm"},{"key":"2024101410522347600_i2331-348X-29-5-456-b47","first-page":"11","article-title":"Intensive rehabilitation can be tolerated by adolescents with postural orthostatic tachycardia syndrome (POTS)","volume":"20","author":"Kempert,","year":"2018","journal-title":"Pediatric Pain Letter"},{"issue":"6","key":"2024101410522347600_i2331-348X-29-5-456-b48","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s10286-008-0494-8","article-title":"Head-up sleeping improves orthostatic tolerance in patients with syncope","volume":"18","author":"Cooper","year":"2008","journal-title":"Clin Auton Res"},{"issue":"2","key":"2024101410522347600_i2331-348X-29-5-456-b49","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpeds.2014.04.014","article-title":"Abdominal and lower-extremity compression decreases symptoms of postural tachycardia syndrome in youth during tilt table testing","volume":"165","author":"Heyer","year":"2014","journal-title":"J Pediatr"}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/29\/5\/456\/3441632\/i2331-348x-29-5-456.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/29\/5\/456\/3441632\/i2331-348x-29-5-456.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T18:41:41Z","timestamp":1738780901000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/29\/5\/article-p456.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,10,14]]},"published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-29.5.456","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"value":"2331-348X","type":"electronic"},{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}